[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346760-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346760-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","loss-of-pik3ca-allows-in-vitro-growth-but-not-in-vivo-progression-of-kras-mutant-lung-adenocarcinoma-in-a-syngeneic-orthotopic-implantation-model","Loss of PIK3CA Allows In Vitro Growth but Not In Vivo Progression of KRAS Mutant Lung Adenocarcinoma in a Syngeneic Orthotopic Implantation Model","","Constitutively active KRAS mutations are common in lung cancers, yet the contribution of its downstream PI3K pathway to tumor progression remains unclear. This study evaluates whether PIK3CA is required for tumor growth in vitro and in vivo using engineered murine lung adenocarcinoma cells with defined oncogenic KRAS and tumor-suppressor status. PIK3CA deletion does not affect survival or growth in vitro, but it reduces growth rate and eliminates in vivo tumor progression after orthotopic implantation. Gene expression suggests oxidative stress sensitivity in PIK3CA-deficient cells, reinforced by hydrogen peroxide and diethyl maleate challenges.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/loss-of-pik3ca-allows-in-vitro-growth-but-not-in-vivo-progression-of-kras-mutant-lung-adenocarcinoma-in-a-syngeneic-orthotopic-implantation-model/346760/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/loss-of-pik3ca-allows-in-vitro-growth-but-not-in-vivo-progression-of-kras-mutant-lung-adenocarcinoma-in-a-syngeneic-orthotopic-implantation-model/346760.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the study on KRAS-mutant lung adenocarcinoma?","Question",{"text":63,"@type":64},"The study investigates whether PIK3CA is required for tumor growth and progression downstream of oncogenic KRAS, comparing effects in vitro and in vivo.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does PIK3CA loss affect tumor behavior in vitro versus in vivo?",{"text":68,"@type":64},"PIK3CA deletion does not impair cell survival or growth in vitro but reduces growth rate; in vivo, PIK3CA is absolutely required for tumor progression in an orthotopic syngeneic implantation model.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence indicates oxidative stress as a vulnerability of PIK3CA-deficient cells?",{"text":72,"@type":64},"Gene expression profiles from cultured cells suggest oxidative stress vulnerability, and experiments show increased sensitivity of PIK3CA-deficient KPA cells to hydrogen peroxide and diethyl maleate compared with control lines.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346760,1790605747,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Article  \nLoss of PIK3CA Allows In Vitro Growth but Not In Vivo Progression of KRAS Mutant Lung Adenocarcinoma in a Syngeneic Orthotopic Implantation Model  \nAbigail L. Booth 1,2, Giuseppe Caso 1, Barbara Rosati 1,3, Ya-Ping Jiang 1, Wei-Xing Zong 4, Richard Z. Lin 1,5 and Harold Bien 5,1, *  \nAcademic Editor: Alexander Dietrich  \nReceived: 5 February 2026  \nRevised: 6 March 2026  \nAccepted: 10 March 2026  \nPublished: 12 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Physiology & Biophysics, Stony Brook University, Stony Brook, NY 11794, USA; [abigail.booth@stonybrook.edu](abigail.booth@stonybrook.edu) (A.L.B.); [richard.lin@stonybrook.edu](richard.lin@stonybrook.edu) (R.Z.L.)  \n2 Molecular and Cellular Biology Graduate Program, Stony Brook University, Stony Brook, NY 11794, USA  \n3 Stony Brook University Single Cell and Spatial Multiomics Facility, Stony Brook University, Stony Brook, NY 11794, USA  \n4 Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey, Piscataway, NJ 08854, USA  \n5 Northport VA Medical Center, Northport, NY 11768, USA  \n* [Correspondence: harold.bien@va.gov](Correspondence: harold.bien@va.gov)  \nAbstract  \nConstitutively active KRAS mutations are highly prevalent in lung cancers, but the direct role of its downstream phosphatidylinositol 3-kinase (PI3K) pathway in tumor progression remains unclear. A previous study established the requirement for PIK3CA, the alpha catalytic isoform, in lung tumor development in mouse models with an intact Trp53 tumor suppressor. In this study, we further investigated the requirement of PIK3CA for tumor growth both in vitro and in vivo. We first generated a “KPA” cell line by genetically deleting Pik3ca from a murine lung adenocarcinoma “KP” cell line harboring oncogenic KrasG12D and lacking Trp53 . We also examined the requirement for STK11, a tumor suppressor and metabolic regulator frequently co-mutated with KRAS in lung cancer. We found that Pik3cais not required for cell survival and growth in vitro, even under anchorage-independent conditions, but reduced the growth rate by 15% . We next orthotopically implanted KPand KPA cells into syngeneic mice and found that PIK3CA is absolutely required for tumor progression, even in the absence of Trp53 . Implantation of KP cells, or a “KPS” cell line lacking the Stk11 gene, led to rapid tumor growth and death of all host animals. In contrast, mice implanted with KPA cells all survived with no detectable lung tumors. The gene expression profiles from cultured cell lines suggest oxidative stress as a potential vulnerability of KPA cells. Indeed, we found KPA cells were more sensitive to hydrogen peroxide and diethyl maleate-induced oxidative stress as compared to KP and KPS cells. Together, these results indicate that PIK3CA is not required for lung cancer cell growth induced by mutant KRAS in vitro but is essential for in vivo progression and growth.  \nKeywords: PIK3CA; STK11; lung cancer; LUAD; KRAS; orthotopic model  \n1. Introduction  \nLung adenocarcinoma (LUAD) accounts for about 40% of non-small cell lung cancer (NSCLC) cases and often carries oncogenic KRAS mutations, including KRASG12C, KRASG12D, and KRASG12V [1,2] . While the canonical RAS pathway primarily activates the MAPK signaling cascade, the phosphatidylinositol 3-kinase (PI3K) pathway is also  \nactivated downstream of RAS signaling [3–6] . This occurs upon active GTP-bound KRAS binding and signaling through direct binding to the catalytic p110 subunit of the PI3K complex at the RAS-binding domain (RBD) [7] . In solid tumors, the predominant catalytic isoform of the PI3K pathway is the alpha isoform encoded by the PIK3CA gene, which is required for tumor growth and maintenance [5,6,8] . Activated PIK3CA produces phosphatidylin","cbCainTjWo1yIMiQ","https://ap.wps.com/l/cbCainTjWo1yIMiQ","pdf",2392164,"English","# Abstract\n# Introduction\n## RAS and PI3K signaling in lung adenocarcinoma\n## PI3K/AKT/mTOR as therapeutic targets and clinical challenges\n## PIK3CA and STK11 alterations in KRAS-mutant LUAD","[{\"question\":\"What is the main purpose of the study on KRAS-mutant lung adenocarcinoma?\",\"answer\":\"The study investigates whether PIK3CA is required for tumor growth and progression downstream of oncogenic KRAS, comparing effects in vitro and in vivo.\"},{\"question\":\"How does PIK3CA loss affect tumor behavior in vitro versus in vivo?\",\"answer\":\"PIK3CA deletion does not impair cell survival or growth in vitro but reduces growth rate; in vivo, PIK3CA is absolutely required for tumor progression in an orthotopic syngeneic implantation model.\"},{\"question\":\"What evidence indicates oxidative stress as a vulnerability of PIK3CA-deficient cells?\",\"answer\":\"Gene expression profiles from cultured cells suggest oxidative stress vulnerability, and experiments show increased sensitivity of PIK3CA-deficient KPA cells to hydrogen peroxide and diethyl maleate compared with control lines.\"}]","Loss of PIK3CA Allows In Vitro Growth but Not In Vivo Progression of KRAS Mutant Lung Adenocarcinoma in a Syngeneic Orthotopic Implantation Model | PDF",1790062646,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ad3a5ad11579fbe4e2e146541bae5cb.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73b8249f8f6c056f74b1155f4ae531e9.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf665398049ce00c9660228f6a9799d4.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19d6915d983df08fb52f426238a5f813.webp",980,1385]